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Dapsone (4,4'-diaminodiphenylsulfone, DDS), a potent anti-inflammatory agent, is widely used 
in the treatment of leprosy and several chronic inflammatory skin diseases. Dapsone therapy 
rarely results in development of dapsone hypersensitivity syndrome, which is characterized by 
fever, hepatitis, generalized exfoliative dermatitis, and lymphadenopathy. Here, we describe the 
case of an 11-year-old Korean boy who initially presented with high fever, a morbilliform skin rash, 
generalized lymphadenopathy, hepatosplenomegaly, and leukopenia after 6 weeks of dapsone intake. 
Subsequently, he exhibited cholecystitis, gingivitis, colitis, sepsis, aseptic meningitis, disseminated 
intravascular coagulation, syndrome of inappropriate antidiuretic hormone secretion, pneumonia, 
pleural effusions, peritonitis, bronchiectatic changes, exfoliative dermatitis, and acute renal failure. 
After 2 months of supportive therapy, and prednisolone and antibiotic administration, most of the 
systemic symptoms resolved, with the exception of exfoliative dermatitis and erythema, which 
ameliorated over the following 4 months. Agranulocytosis, atypical lymphocytosis, aseptic meningitis, 
and bronchiectatic changes along with prolonged systemic symptoms with exfoliative dermatitis were 
the most peculiar features of the present case.
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Introduction
Dapsone (4,4´-diaminodiphenylsulfone, DDS) is a potent antibiotic and anti-
inflammatory agent that belongs to the sulfonamide drug class. It is primarily used in 
the management of leprosy, bullous dermatoses and other refractory inflammatory skin 
diseases. Drug-induced hypersensitivity syndrome (DIHS), also called drug rash with 
eosinophilia and systemic symptoms (DRESS), is a severe reaction to drugs, such as 
carbamazepine, phenytoin, phenobarbital, allopurinol, minocycline, sulfasalazine, and 
dapsone, mimicking severe sepsis or viral infection. DIHS is usually characterized by 
fever, rash, and multiorgan failure, occurring 1 to 8 weeks after drug introduction. It is 
thought to be an immune-mediated reaction involving macrophage and T-lymphocyte 
activation and cytokine release
1). When features of DIHS have occurred clearly after 
dapsone medication, the term, ‘dapsone hypersensitivity syndrome (DHS)’ is commonly 
used. 
To the best our knowledge, there are few reported cases of DHS with multiorgan 
dysfunction in Korean children
2-4). Most of their symptoms resolved within 2 or 3 weeks 
of steroid treatment, however, one case progressed to coma on 6th hospital day (HD) and 
died a few days later
2). An international review of 336 patients with DHS showed that, 
more than 70% of the patients were from Asia, and the prevalence rate and fatality rate 
of hypersensitivity reactions to dapsone were 1.4% and 9.9%, respectively
5). We report 261 http://dx.doi.org/10.3345/kjp.2013.56.6.260
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a Korean boy who presented with DHS with a review of the 
literature. 
Case report
An 11-year-old Korean boy presented with three days of 
pruri  tic erythematous rashes on both cheeks in a butterfly 
distribution, and circumoral pallor. The following day, he de-
veloped high fever with rice-grain-sized rashes that spread to the 
trunk. The patient’s medical history revealed that he had been 
referred to a dermatological clinic at our hospital 2 months prior 
to presentation due to papular skin lesions on both forearms, 
elbows, and ankles that had appeared 4 months ago, and were 
refractory to conventional therapies. A diagnosis of linear IgA 
bullous dermatosis was made after biopsy, and he was started on 
dapsone at a dose of 50 mg per day for 4 days, then increased 
to 100 mg a day, methylprednisolone 8 mg once a day, and 
ranitidine 75 mg twice a day. A marked improvement of the skin 
lesions was noted after 6 weeks of treatment, which completed 
before he came to pediatric clinic with this new facial rash, and 
fever. Physical examination revealed a lethargic appearance with 
a temperature of 39.0°C, heart rate of 82 beats/min, respiratory 
rate of 20 breaths/min, blood pressure of 120/80 mmHg, injected 
tonsils, hepatosplenomegaly, and bilateral enlargement of 
lymph nodes in the axillary and inguinal regions up to 3 cm 
in diameter. Given these findings, the patient was admitted 
to the pediatric ward with a working differential diagnosis of 
drug hypersensitivity versus autoimmune disease versus viral 
infection.
Initial blood count revealed a total leukocyte count of 600/
mm
3 (neutrophil 6%, lymphocyte 91%, eosinophil 0%), a 
hemoglobin of 11.8 g/dL, reticulocyte count of 3.4%, and platelet 
count of 180.000/mm
3. The white blood cell count, checked 5 
weeks prior to admission, was 4,000/mm
3 with 46% neutrophils. 
Atypical lymphocytes were observed, and the differential count 
fluctuated between 4% and 29% during the first 2 weeks of 
hospitalization (Fig. 1). No eosinophilia was noted. A blood 
chemistry panel showed an aspartate aminotransferase of 107 IU/
L, alanine aminotransferase of 101 IU/L, total bilirubin of 1.1 mg/
dL, and a methemoglobin of 1.1%. Serologic tests for Epstein-
Barr virus, cytomegalovirus, parvovirus, measles, antinuclear 
antibody, anti-ds DNA antibody, and lupus anticoagulant 
antibody were all negative. A polymerase chain reaction assay 
for 7 species of common respiratory viruses with nasal aspirates 
was positive for parainfluenza virus. Blood culture results on 1st 
HD  were negative.
Dapsone was stopped immediately after the onset of fever. 
After admission, antihistamines, ibuprofen, prednisolone, am-
picillin-sulbactam and intermittent dexamethasone injection 
were given. Prednisolone was administered at a dose of 1 mg/ 
kg/day for 8 weeks. A subsequent study with ultrasound and 
computerized tomography (CT) of the abdomen revealed thicken-
ing of the gall bladder wall with some sludge, localized edema 
around the gall bladder, and moderate hepatosplenomegaly. 
Persistent fever, vomiting, dyspnea, and hypotension led to 
sequential blood cultures and ampicillin-sulbactam was replaced 
by meropenem from 8th HD. Culture results were positive for 
Klebsiella pneumoniae on the 8th HD, but negative on the 
9th HD after introduction of meropenem for 1 day. Analysis 
of cerebrospinal fluid (CSF) on the 10th HD day showed a 
Fig. 1. Atypical lymphocytes detected in the patient’s peripheral blood 
for 17 days. These cells were activated T-lymphocytes that appear to 
contribute to the pathogenesis of dapsone hypersensitivity syndrome. 
Fig. 2. High-resolution chest computed tomography image of the lungs 
taken at 5 week after presentation shows bronchiectatic changes, 
although some degree of motion artifacts is noted. The arrowhead in 
the right lung indicates cystic bronchial dilatation (A). The small arrows 
represent dilated bronchial lumen with wall thickening. The tram-track 
lines parallel to each other in the left lung (A) and the ring signs in cross 
sectioned view of bronchi in the right lungs (B, C), and the cylindrical 
shape in the left lung (C) all suggest dilated bronchi.http://dx.doi.org/10.3345/kjp.2013.56.6.260
Choi SY, et al. • Dapsone hypersensitivity syndrome in a child
262
leukocyte count of 675 cells/mm
3 (lymphocytes 100%), protein 
level of 136 mg/dL, and glucose level of 46 mg/dL. The CSF 
cultures for bacteria and fungi were negative. The patient’s 
dyspnea and hypotension improved 2 days later and follow-
up CSF study 5 days later showed a leukocyte count of 9 cells/
mm
3 (lymphocytes 62%, monocytes 38%), protein level of 33 
mg/dL, and glucose level of 74 mg/dL. Sepsis, which appeared 
to be associated with Klebsiella pneumoniae, was followed by 
colitis, disseminated intravascular coagulation, syndrome of 
inappropriate antidiuretic hormone secretion, aseptic meningitis, 
pneumonia, pleural effusions, and peritonitis. Starting on 35th 
HD, he had renal failure for 10 days with fluctuating serum 
creatinine levels from 1.8 to 3.5 mg/dL. Chest CT, taken on 38th 
HD because of recurrent severe productive cough and rales, 
despite normal chest X-ray finding, showed tubular and cystic 
bronchiectatic changes (Fig. 2). Out of 19 blood cultures during 
the hospital stay, there was only one positive result for Klebsiella 
pneumoniae on 8th HD. The culture results were negative the 
following day with only three doses of meropenem. At that 
point, it is uncertain whether it is a rapid response to new 
antibiotics or contamination. 
The maculopapular rashes initially developed on the face 
and trunk of the patient became confluent, spread to involve 
Fig. 3. Desquamative changes of the patient’s face during the seventh 
week of the illness (A), and erythroderma during the twelfth week (B).
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Fig. 4. Clinical course of the patient over 2 months of hospitalization. Blood culture (BC) on the 
first hospital day (HD) yielded negative results. Klebsiella pneumoniae was cultured from the blood 
on the eighth HD; however, the result of BC the next day, after only three doses of meropenem 
treatment, showed negative. Cerebrospinal fluid (CSF) study on the tenth HD showed a leukocyte 
count of 675 cells/mm
3 (lymphocytes 100%), protein level of 136 mg/dL, and glucose level 
of 46 mg/dL. The CSF culture for bacteria and fungi yielded negative results. A follow-up CSF 
study 5 days later showed 9 cells/mm
3 (lymphocytes 62%, monocytes 38%), protein level of 
33 mg/dL, and glucose level of 74 mg/dL. DIC, disseminated intravascular coagulation; SIADH, 
syndrome of inappropriate antidiuretic hormone secretion; ARF, acute renal failure; AST, aspartate 
aminotransferase; ALT, alanine aminotransferase; WBC, white blood cell.263 http://dx.doi.org/10.3345/kjp.2013.56.6.260
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the entire body, and lately developed secondary desquamative 
changes in the 7th week of illness. With 2 months of supportive 
care, most of the patient’s systemic symptoms resolved, with 
the exception of the skin scaling and generalized red tone 
or ‘erythroderma’ (Fig. 3), both of which slowly faded over 
the following 4 months. A severe neutropenia with absolute 
neutrophil counts ranged from 0 to 36/mm
3 that lasted the first 
2 weeks of hospitalization. It was slowly replaced by moderate 
neutrophilic leukocytosis after administration of prednisolone. 
All of the clinical events that occurred to the patient during the 
admission period are shown in the diagram (Fig. 4)
Discussion
By definition, sulfonamides are compounds that contain 
a sulfamoyl group (-SO2NH2). They were first synthesized as 
dyes derived from coal tar for the fabric industry in the early 
20th century
6). Dapsone is the structurally the simplest of 
all the sulfones. It was mainly used as a first-line treatment 
for leprosy
7,8), and has also been used for a number of other 
dermatologic diseases, including Hailey-Hailey disease, bullous 
pemphigoid, acne, linear IgA dermatosis, urticarial vasculitis, 
and leukocytoclastic vasculitis
9,10).
Orally administered dapsone is absorbed readily from the 
gastro  intestinal tract with an estimated bioavailability of grea-
ter than 86%. After absorption via the gastrointestinal tract, 
dapsone is transported to the liver by portal circulation, where 
it is metabolized via either acetylation or N-hydroxylation
7). 
Dapsone N-hydroxylation is mediated primarily by human 
liver microsomal enzymes P450 3A4, 2C6, and 2C11
11,12). This 
pathway is thought to represent the initial step in the formation 
of toxic intermediate metabolites. While sulfonamide-induced 
hypersensitivity syndrome typically appears 10 or more days 
after exposure
13), dapsone-induced disease usually develops more 
than 4 weeks after starting the medication
11). Additionally, the 
data suggest that dapsone-induced hypersensitivity syndrome 
carries a higher risk of hepatic involvement
11,14). Our patient 
developed DHS six weeks after drug introduction. 
The precise pathogenetic mechanism of adverse drug reactions 
is unclear. However, delayed hypersensitivity directed by 
drug-specific T cells seems to be involved, since widespread 
skin lesions, generalized lymphadenopathy, hepatitis, and 
sometimes nephritis or pneumonitis develop 2 to 8 weeks 
after administration of the offending drugs, and these clinical 
features last even after withdrawal of the drugs. Visible atypical 
lymphocytes in peripheral blood as in our case support this 
hypothesis. 
Another common side effect of dapsone therapy is dose 
dependent hematologic problems, including methemoglobinemia 
and hemolytic anemia, both of which result primarily from 
hydroxylamine and other hydroxylated metabolites acting as 
potent oxidants
15). Those findings were not observed in our case. 
Other rare, serious, and unpredictable hematologic side effects 
associated with dapsone include agranulocytosis
11). Prolonged 
agranulocytosis increases a person's risk for infections and 
sepsis. However, one cannot conclude that the sepsis in the case 
was caused solely by an infection.
The pathogenesis of meningitis and bronchiectatic changes 
in this case was one of the major questions. It is possible that 
the patient had partially treated bacterial meningitis (PTBM) 
since 3 doses of intravenous meropenem was given before the 
CSF cultures became negative. However, drug induced aseptic 
meningitis (DIAM) due to dapsone, or even to amoxicillin 
or ibuprofen, other possible scenarios in this case, cannot 
be excluded on the basis of the CSF profiles. Although there 
is no report that DIAM is related to dapsone, DIAM due to 
trimethoprim-sulfamethoxazole or ibuprofen
16-19) is well-known. 
CSF findings alone, however, cannot discriminate DIAM from 
other disease, such as PTBM or viral meningitis
17-19). Reports 
of DIAM following ingestion of drugs in patients with diverse 
autoimmune disease
18), or a report of high CSF protein level of 
312 mg/dL in a patient with DIAM
19) provide us meaningful 
reference. The bronchiectatic changes with uncommon cystic 
dilatation, which were first noted on 38th HD, are another 
intriguing point. The term, bronchiectatic change, was used 
instead of bronchiectasia since follow-up study was not made. 
Dapsone is known to induce pneumonitis
20), but we failed to 
find a report indicating a relationship between dapsone and 
bronchiectasis or bronchiectatic changes. While it seems to 
be safe to attribute the causes of the patient’s meningitis and 
bronchiectatic changes to infections, or, at least, interplay 
between infection and a drug reaction, it is very challenging to 
attribute the causes primarily to the drug reaction.  
Systemic steroids are known to be effective in treating DHS. 
In the case presented here, prednisolone was used at a dose 
of 1 mg/kg/day for 8 weeks. DIHS is usually treated with oral 
corticosteroids in dose of 1–1.5 mg/kg/day. It needs to be deter-
mined whether higher steroid doses can produce better results. 
Notably, the steroid dose should not be tapered too early, as 
dapsone toxic metabolites can persist in organs for up to 35 
days via protein binding and the enterohepatic circulation
11), and 
worsening of dermatitis and hepatitis can occur as a rebound 
phenomenon
15). After 2 months of hospital treatment, most of 
the systemic symptoms were resolved, with the exception of the 
skin scaling and erythema which faded over the following 4 
months. 
Although, DHS is rarely encountered in the field of pediatrics, 
clinicians need to familiarize themselves with the prominent 
features of DHS which may be prototypical of all DIHS. In our http://dx.doi.org/10.3345/kjp.2013.56.6.260
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case, agranulocytosis, atypical lymphocytosis, sepsis, aseptic 
meningitis, bronchiectatic changes, and prolonged course are 
some of the most peculiar findings that can differentiate this 
case from others. 
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